Journal
VACCINE
Volume 41, Issue 31, Pages 4497-4507Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2023.06.003
Keywords
Cytomegalovirus; Congenital infection; Human monoclonal antibody; Epitope; Neutralization; Antibody-dependent cell-mediated; phagocytosis
Categories
Ask authors/readers for more resources
Congenital cytomegalovirus (CMV) infections are a major cause of hearing loss and neurological disabilities in children, highlighting the importance of developing CMV vaccines. However, the efficacy of the current MF59-adjuvanted glycoprotein B vaccine in protecting against natural infection is limited, and non-neutralizing functions of antibodies may play important roles in pathogenesis and vaccine design.
As congenital cytomegalovirus (CMV) infections are the leading non-genetic cause of sensorineural hearing loss and significant neurological disabilities in children, the development of CMV vaccines should be given the highest public health priority. Although MF59-adjuvanted glycoprotein B (gB) vaccine (gB/ MF59) is safe and immunogenic, its efficacy in terms of protection from natural infection was around 50 % in clinical trials. Although gB/MF59 induced high antibody titers, anti-gB antibodies contributed little to the neutralization of infection. Recent studies have found that non-neutralizing functions, including antibody-dependent phagocytosis of virions and virus-infected cells, are likely to play important roles in pathogenesis and vaccine design. Previously, we isolated human monoclonal antibodies (MAbs) that reacted with the trimeric form of gB ectodomain and found that preferential epitopes for neutralization were present on Domains (Doms) I and II of gB, while there were abundant non-neutralizing antibodies targeting Dom IV. In this study, we analyzed the phagocytosis activities of these MAbs and found the following: 1) MAbs effective for phagocytosis of the virions targeted Doms I and II, 2) the MAbs effective for phagocytosis of the virions and those of virus-infected cells were generally distinct, and 3) the antibodydependent phagocytosis showed little correlation with neutralizing activities. Taking account of the frequency and levels of neutralization and phagocytosis, incorporation of the epitopes on Doms I and II into developing vaccines is considered desirable for the prevention of viremia. & COPY; 2023 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available